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Abstract
Purpose Most studies on congenital pseudarthrosis of the
tibia (CPT) report on the short-term union rate and
refracture rate but do not take into account the long-term
outcome. This review includes patients treated with an
Ilizarov bone transport, who all reached skeletal maturity.
It describes long-term results and highlights any prognostic
factors that could predict the final outcome.
Methods The records of patients with CPT treated with
an Ilizarov bone transport in our institution were retro-
spectively evaluated.
Results A total of 12 consecutive patients were studied.
The mean follow-up was 24.5 years (range 6–39 years).
Primary consolidation was seen in ten patients (83 %). Half
of these patients had a refracture. At final follow-up, eight
patients experienced union and four remained un-united, of
whom one had an amputation.
Conclusions The present data confirm a good primary
healing rate. However, tibial union at final follow-up was
only seen in 67 %, indicating that refracture is the main
issue. United bone is often of inferior biological and
mechanical quality, so lifetime protection with intrame-
dullary devices, braces or a combination of both is
recommended.
Keywords Congenital pseudarthrosis of the tibia 
Ilizarov bone transport  Neurofibromatosis
Introduction
Congenital pseudarthrosis of the tibia (CPT) remains one
of the most challenging problems in paediatric orthopaedic
surgery due to its low incidence, unclear aetiopathogenesis
and resistance to therapy. There is a definite link with
neurofibromatosis type 1 (NF-1), an association already
described in 1937 [1]. For non-NF patients, the
aetiopathogenesis is completely unknown, but the clinical
presentation is perfectly comparable and has the same
reluctance to healing. Treatment often requires complete
resection of the affected area and a reconstruction using
intramedullary stabilisation and bone grafting, vascularised
fibular transplant or Ilizarov bone transport [2]. Also, the
combined use of these methods and bone morphogenetic
protein 2 or 7 have been described [3–6]. Comparison of
the results of different methods and even within the same
technique is difficult due to variable follow-up periods,
different criteria for healing and lack of long-term follow-
up. This review includes a series of 12 patients treated with
an Ilizarov bone transport with a long-term follow-up. It
describes their final outcome and any prognostic factors
contributing to the evolution and long-term result.
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Patients and methods
The records of patients with CPT treated in our institution
were retrospectively evaluated. Only those patients who
had been treated with an Ilizarov bone transport and had
reached skeletal maturity were further studied. The treat-
ment consisted of extensive debridement of the pseu-
darthrosis (a segmental resection of the pseudarthrosis site)
and Ilizarov bone transport. If standard follow-up radio-
graphs failed to demonstrate signs of bone healing after
6–10 weeks, autologous bone grafting of the docking site
was performed (OP-1 in one patient). There was no
intention to obtain a united fibula. The investigated items
included sex, age at first visit, affected side, length of
follow-up, Crawford classification, age at first surgery,
outcome, number and type of surgical procedure, and age
at each intervention. Also, the presence or absence of
refracture was recorded, the refracture-free interval,
deformities and leg length discrepancy (LLD) after the
final treatment, walking aids and status of the fibula.
The outcome was classified into three groups: union,
non-union or amputation. Union was radiographically
defined as restoration of cortical integrity with bridging
callus across minimally three visible cortices on antero-
posterior and lateral views, and clinically no pain at the
fracture site on palpation and full weight-bearing.
Residual deformities were evaluated on radiographs in
the mediolateral and anteroposterior planes by measuring
respectively the lateral distal tibia angle (LDTA) and the
anterior distal tibia angle (ADTA). Fibula status was
radiographically determined as union, non-union or
resection.
Results
Patient demographics (Table 1)
A total of 12 consecutive patients (eight male, four
female) with CPT treated between 1974 and 2007 at our
institution were studied. The right/left ratio of the affected
side was 7/5. The mean follow-up was 24.5 years (range
6–39 years). The average age at first visit was 4.7 years
(range 0–16 years). According to Crawford’s classifica-
tion, two tibiae showed a type 1 lesion (sclerosis). There
was twice a type 3 cystic lesion and on four occasions
there was a type 4 frank pseudarthrosis. From four
patients, there were no original radiographs available
allowing any classification. The pseudarthrosis site was in
the distal third of the tibia in all patients except in one
(middle third).
Surgical procedures (Table 2)
The average age at the first intervention was 5.8 years
(range 1–17 years). The number of procedures, including
previous and additional surgeries, was a minimum of three
and a maximum of 12 per patient in the total of almost 90
surgeries in 12 patients. Sixty of these surgical procedures
were performed to obtain union, 17 to correct malalign-
ment or shortening, six for relief of ankle pain (tibiotalar
arthrodesis) and six for revision after complications such as
infection or loosening of pins. Bone transport was per-
formed in 20 surgeries, Ilizarov circular frame fixation and
compression in 19, intramedullary pinning in five and
intramedullary nailing in two surgeries. Autologous bone
grafting was used 11 times, bone morphogenetic protein 7
once and segmental fibular resection twice.
Twenty-eight interventions were performed prior to the
index operation. Ilizarov circular frame fixation and com-
pression was done 11 times, intramedullary nailing twice,
intramedullary pinning five times, autologous bone grafting
four times, corrective osteotomy twice, Ilizarov lengthen-
ing three times and a pantalar arthrodesis once.
Outcome (Table 3)
At final follow-up, in eight patients (67 %), the tibia healed
and four were left un-united. The average age at the first
surgical procedure was 4.3 years (range 1–9 years) and 9
years (range 1–17 years) respectively. The age at final
union was, on average, 16.5 years (range 9–36 years).
Primary consolidation, described as union after the ini-
tial treatment, was seen in ten patients (83 %). However,
half of these had a refracture during follow-up. A second
Ilizarov treatment again achieved successful union in three
cases. In one patient, tibial union could not be achieved and
in another patient, a below-the-knee amputation had to be
done. The refracture-free interval was three months, two
years, four years and 18 years and unknown in one patient,
respectively. Figures 1 and 2 describe the primary union
rate and refracture rate for the three age groups (age at first
surgical procedure).
Associated fibular non-union was seen in nine cases and
segmental fibular resection was performed in two patients.
Five patients had a tibiotalar arthrodesis and two patients
had a pantalar arthrodesis at final follow-up.
Two out of three patients with tibial union and a native
ankle joint had a residual ankle valgus deformity (LDTA
\80). Both had a concomitant fibular pseudarthrosis. One
patient had a residual ankle varus deformity (LDTA 107).
The mean ADTA in these patients was 90, indicating a
slight residual antecurvatum deformity.
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The median residual LLD was 0 mm. One patient with a
persistent non-union sustained a residual shortening of
265 mm at the end of growth.
At final follow-up, four out of eight patients with united
tibiae had walking aids (one with a brace, three patients
with orthopaedic shoes). Amongst the non-union patients,
two had a prosthesis (one amputation, one severe shorten-
ing), one an ankle foot orthosis and one orthopaedic shoes.
Discussion
Historically, the treatment of congenital pseudarthrosis is
extremely challenging, as it is difficult to obtain and maintain
a solid union. The original described techniques, such as
Boyd’s onlay grafting [7], McFarland’s support graft [8] or
Sofield’s rodding technique [9], were faced with multiple
problems. They were abandoned in favour of more rigid
intramedullary rodding procedures or Ilizarov circular frame
fixation [10], often combined with extensive autologous
grafting. However, due to the extent of the affected bone,
large resections often create large defects to be reconstructed.
Two methods can adequately deal with that problem, i.e. the
vascularised fibular graft and Ilizarov’s bone transport
method, but they do not always guarantee a solid union.
In the current study, the final long-term healing rate with
follow-up till many years after reaching skeletal maturity
was 67 %. At first sight, this is perfectly comparable to the
results of the Norwegian group of Horn et al., who reported
66 % of healing with the Ilizarov technique in a group of
22 patients. However, this was primary healing in a
heterogeneous group (15 Ilizarov treatments and six bone
transports) and many patients refractured afterwards,
making the ultimate outcome less clear [11]. In their large
multicenter survey made by the European Paediatric
Orthopaedic Society (EPOS)—in which the results of some
of these patients are also included—Grill et al. reported a
healing rate of 59.20 % in 20 segmental bone transports
[12]. Guidera et al. described a union rate of 82 % in 11
patients (nine bone transports) but had a short follow-up
(three years) and no union criteria [13]. A more recent
study of 12 patients treated with a bone transport reported
excellent results in eight patients, good in three and poor in
one. However, no further details were given and the mean
follow-up was five years [14]. Boero et al. had a healing
rate of 65 % in 21 patients with a mean follow-up period of
two years (three bone transports, none healed) and Cho
et al. achieved union in 22 out of 23 patients, with a mean
follow-up of 9.2 years (four bone transports) [15, 16].
Table 1 Patient demographics. Concerning the level of the pseudarthrosis site, 2/3 indicates the middle third of the tibia and 3/3 the distal third







1 M R 21 9 10 1 3/3 No
2 M L 20 14 6 Unknown 3/3 Yes
3 M L 29 16 13 4 3/3 No
4 M L 40 1 39 Unknown 3/3 Yes
5 F L 43 4 39 4 3/3 No
6 M R 27 0 27 4 3/3 No
7 F R 30 9 21 3 3/3 No
8 M L 32 0 32 Unknown 3/3 Yes
9 M R 28 2 26 3 3/3 Yes
10 F R 33 1 32 Unknown 2/3 Yes
11 M R 26 0 25 1 3/3 No
12 F R 24 0 24 4 3/3 No
Table 2 Age at first surgical procedure and number of surgical
procedures. The numbers in parentheses are the numbers of proce-
dures performed prior to the index operation
Patient
number




1 9 4 (0)
2 17 4 (0)
3 16 10 (3)
4 1 6 (1)
5 4 [3 ([1)
6 1 12 (9)
7 9 10 (1)
8 2 11 (5)
9 4 12 (4)
10 2 3 (2)
11 1 7 (2)
12 4 5 (0)
J Child Orthop (2015) 9:319–324 321
123
However, in our study, four out of eight patients in the
union group had walking aids (three orthopaedic shoes and
one a protective brace). On the other hand, these patients
were functionally well and ambulated pain-free without
crutches or a walking stick. The outcome is considered good
in one-third, acceptable in one-third and bad in one-third.
It is clear that the key strength of this study is the long-
term follow-up (even up to 40 years!) in a homogeneous
group of patients treated with a bone transport.
Table 3 Outcome
Patient number Outcome Refracture Refracture-free interval (years) Status tibiotalar (TT) and subtalar (ST) joint Status fibula
1 Union Yes 4 TT fusion Non-union
2 Non-union No Non-union
3 Non-union Yes 0.25 TT ? ST fusion Non-union
4 Union No TT fusion Non-union
5 Union Yes Unknown Non-union
6 Amputation Yes 18 Prior TT ? ST fusion Amputation
7 Union No TT fusion Non-union
8 Union No TT fusion Non-union
9 Union Yes 2 Non-union
10 Non-union No Non-union
11 Union No TT fusion Resected
12 Union No Resected
Patient number LDTA () ADTA () LLD (mm) Walking aids
1 – – 15 Brace
2 – – 0 AFO
3 – – -40 Orthopaedic shoes
4 – – -5 Orthopaedic shoes
5 77 96 0 Insoles
6 – – Amputation Prosthesis
7 – – 0 Insoles
8 – – 64 None
9 79 81 -30 Orthopaedic shoes
10 – – -265 Prosthesis
11 – – -30 None
12 107 93 10 Orthopaedic shoes
Fig. 1 Primary union rate for the three age groups (age at first
surgical procedure)
Fig. 2 Refracture rate for the three age groups (age at first surgical
procedure)
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Even if a union seems to be obtained, a refracture within
the first couple of years is not uncommon, as was observed
in five out of ten patients (50 %) who had a healed tibia
after the initial treatment. The refracture-free interval was,
on average, 6.1 years. One adult patient even sustained a
refracture after 18 years, suggesting that, even after
remodelling and reaching skeletal maturity, bone of normal
quality cannot be guaranteed. This might be an argument
for protective bracing or prophylactic rodding of the tibia.
Novel insights in cellular pathways showed that a mutation
in the NF-1 gene results in a loss of neurofibromin activity,
which disturbs the osteoblast activity [17]. This may sug-
gest that NF patients are more prone to late refracture. This
is consistent with some reports in the literature [18–20],
although some studies suggest that NF has no influence on
the final outcome [21–23]. In the present study, four out of
five patients who sustained a refracture were NF negative.
Many studies have drawn attention to the age at which a
first surgical procedure has to be initiated. Almost half a
century ago, Boyd and Sage advocated surgery as early as
possible, and this point of view is still defended by some
authors [22, 24, 25]. However, these authors found that
intramedullary nailing with bone grafts obtains better
fusion rates and has less influence on the growth in children
under the age of 3 years. On the other hand, Grill et al.
reported an overall healing rate of only 64 % in children
under 3 years old, whereas the age category between 6 and
9 years obtained a union in 92 % of cases [12]. In our
study, the primary healing rate was 80 % (4/5) when the
first surgery was done between 0 and 3 years old, 100 % (5/
5) between 4 and 10 years old, and 50 % (1/2) after the age
of 10 years. The refracture rates in these age groups were
25 % (1/4), 60 % (3/5) and 100 % (1/1), respectively.
However, these groups are small and more studies with
larger cohorts would be useful. Nevertheless, based on
Grill et al.’s results and also supported by the studies of
Ghanem et al. and Boero et al. [12, 15, 26], who demon-
strated that the Ilizarov method in very young children was
associated with low success rates, we prefer nowadays to
postpone surgery till after the age of 4 years. On the con-
trary, it seems that beginning surgical treatment at an older
age, such as around 10 years old, should also be avoided.
Moreover, disuse atrophy of the bone and deformity of the
ankle joint will be aggravated. In this study, both patients
for whom the surgical treatment was started after the age of
10 years old did not obtain union at final follow-up.
Another interesting finding is that the number of surgical
procedures does not seem to influence the final outcome, as
union was even obtained in patients after multiple
surgeries.
The nature of the pathology and its complex treatment
often lead to the development of deformities and leg length
discrepancies. The most frequent deformity is a valgus
ankle [12]. Valgus problems are thought to be associated
with insufficient lateral buttress provided by the distal
fibula. This is in accordance with our observations, which
showed that two out of three patients had an LDTA of less
than 80 and that both had a non-united fibula.
Severe deformities also often necessitate tibiotalar and/
or subtalar arthrodesis. Theoretically, this could lead to
increased stress on the pseudarthrosis site and subsequent
refracture, but this could not be shown in our series, as four
out of seven patients with an arthrodesis united without a
previous refracture.
Residual LLD following successful union was not a
major problem in our study. We observed a median LLD of
0 mm, indicating that the Ilizarov method is a very reliable
method regarding the treatment of residual limb shortening
after multiple procedures.
The importance of fibular stabilisation in the treatment
of CPT has been emphasised by several authors. As pre-
viously mentioned, persistent fibular non-union favours
valgus deformities. Moreover, fibular pseudarthrosis was
also found to be related to failure of tibial union [27]. The
findings of the current study could not support this state-
ment, as all patients had a resected or non-united fibula. As
previously mentioned, there was no intention to obtain
fibular union.
Many patients require multiple revision surgeries and,
even after frequent interventions, limb function can be
severely compromised. Amputation for intractable CPT is
not uncommon and should be considered for patients with a
poor functional result after previous treatments, with very
restricted walking ability, who have a good chance for
improvement in case of correct prosthetic fitting and
absence of stump problems. In a comparative study of gait
and function between healed patients after multiple surg-
eries and those with an amputation, Karol et al. did not find
a difference in the efficiency of gait in one of the two
groups [28].
At final evaluation of our patient group, amputation was
only performed once, as it was estimated throughout the
treatment that this would have no benefit regarding their
function. In general, we would only recommend amputa-
tion if the expected result would surpass the functional
outcome after multiple surgeries.
The present data confirm a primary healing rate of 83 %.
However, tibial union at final follow-up was only seen in
67 %, indicating that refracture is the main issue. United
bone is often of inferior biological and mechanical quality
(small docking site, sclerotic bone with no medullary
cavity, non-united fibula), so lifetime protection with
intramedullary devices, braces or a combination of both is
recommended.
J Child Orthop (2015) 9:319–324 323
123
Compliance with ethical standards
Conflict of interest The authors declare that they have no conflict
of interest.
Ethical approval All procedures performed in studies involving
human participants were in accordance with the ethical standards of
the institutional and/or national research committee and with the 1964
Helsinki declaration and its later amendments or comparable ethical
standards.
Informed consent For this type of study formal consent is not
required.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://crea
tivecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were
made.
References
1. Ducroquet R (1937) A propos des pseudarthroses et inflexions
congenitales du tibia. Acad Chir 63:863–868
2. Lammens J, Fabry G (1992) Reconstruction of bony defects using
the Ilizarov ‘‘bone transport’’ technique. A preliminary report.
Arch Orthop Trauma Surg 111(2):70–72
3. Richards BS, Oetgen ME, Johnston CE (2010) The use of
rhBMP-2 for the treatment of congenital pseudarthrosis of the
tibia: a case series. J Bone Joint Surg Am 92(1):177–185
4. Dohin B, Dahan-Oliel N, Fassier F, Hamdy R (2009) Enhance-
ment of difficult nonunion in children with osteogenic protein-1
(OP-1): early experience. Clin Orthop Relat Res
467(12):3230–3238
5. Fabeck L, Ghafil D, Gerroudj M, Baillon R, Delince´ P (2006)
Bone morphogenetic protein 7 in the treatment of congenital
pseudarthrosis of the tibia. J Bone Joint Surg Br 88(1):116–118
6. Lee FY-I, Sinicropi SM, Lee FS, Vitale MG, Roye DP Jr, Choi
IH (2006) Treatment of congenital pseudarthrosis of the tibia
with recombinant human bone morphogenetic protein-7 (rhBMP-
7). A report of five cases. J Bone Joint Surg Am 88(3):627–633
7. Boyd HB (1941) Congenital pseudarthrosis treatment by dual
bone grafts. J Bone Joint Surg 23:497–515
8. McFarland B (1951) Pseudarthrosis of the tibia in childhood.
J Bone Joint Surg Br 33-B(1):36–46
9. Sofield HA (1971) Congenital pseudarthrosis of the tibia. Clin
Orthop Relat Res 76:33–42
10. Lammens J, Truyen J, Bauduin G, Fabry G (2000) The treatment
of congenital tibial pseudarthrosis. Orthopade 29(1):54–57
11. Horn J, Steen H, Terjesen T (2013) Epidemiology and treatment
outcome of congenital pseudarthrosis of the tibia. J Child Orthop
7(2):157–166
12. Grill F, Bollini G, Dungl P, Fixsen J, Hefti F, Ippolito E et al
(2000) Treatment approaches for congenital pseudarthrosis of
tibia: results of the EPOS multicenter study. European Paediatric
Orthopaedic Society (EPOS). J Pediatr Orthop B 9(2):75–89
13. Guidera KJ, Raney EM, Ganey T, Albani W, Pugh L, Ogden JA
(1997) Ilizarov treatment of congenital pseudarthroses of the
tibia. J Pediatr Orthop 17(5):668–674
14. Patwa J, Patel R (2013) A short series of congenital pseu-
doarthrosis tibia. J Orthop 10(3):123–132
15. Boero S, Catagni M, Donzelli O, Facchini R, Frediani PV (1997)
Congenital pseudarthrosis of the tibia associated with neurofi-
bromatosis-1: treatment with Ilizarov’s device. J Pediatr Orthop
17(5):675–684
16. Cho T-J, Choi IH, Lee SM, Chung CY, Yoo WJ, Lee DY et al
(2008) Refracture after Ilizarov osteosynthesis in atrophic-type
congenital pseudarthrosis of the tibia. J Bone Joint Surg Br
90(4):488–493
17. Crawford AH, Schorry EK (2006) Neurofibromatosis update.
J Pediatr Orthop 26(3):413–423
18. Andersen KS (1972) Congenital angulation of the lower leg and
congenital pseudarthrosis of the tibia in Denmark. Acta Orthop
Scand 43(6):539–549
19. Boyd HB (1982) Pathology and natural history of congenital
pseudarthrosis of the tibia. Clin Orthop Relat Res 166:5–13
20. Crawford AH (1986) Neurofibromatosis in children. Acta Orthop
Scand Suppl 218:1–60
21. McCarthy RE (1982) Amputation for congenital pseudarthrosis
of the tibia. Indications and techniques. Clin Orthop Relat Res
166:58–61
22. Morrissy RT (1982) Congenital pseudarthrosis of the tibia. Fac-
tors that affect results. Clin Orthop Relat Res 166:21–27
23. Paterson D (1989) Congenital pseudarthrosis of the tibia. An
overview. Clin Orthop Relat Res 247:44–54
24. Boyd HB, Sage FP (1958) Congenital pseudarthrosis of the tibia.
J Bone Joint Surg Am 40-A(6):1245–1270
25. Joseph B, Somaraju VVJ, Shetty SK (2003) Management of
congenital pseudarthrosis of the tibia in children under 3 years of
age: effect of early surgery on union of the pseudarthrosis and
growth of the limb. J Pediatr Orthop 23(6):740–746
26. Ghanem I, Damsin JP, Carlioz H (1997) Ilizarov technique in the
treatment of congenital pseudarthrosis of the tibia. J Pediatr
Orthop 17(5):685–690
27. Dobbs MB, Rich MM, Gordon JE, Szymanski DA, Schoenecker
PL (2004) Use of an intramedullary rod for treatment of con-
genital pseudarthrosis of the tibia. A long-term follow-up study.
J Bone Joint Surg Am 86-A(6):1186–1197
28. Karol LA, Haideri NF, Halliday SE, Smitherman TB, Johnston
CE 2nd (1998) Gait analysis and muscle strength in children with
congenital pseudarthrosis of the tibia: the effect of treatment.
J Pediatr Orthop 18(3):381–386
324 J Child Orthop (2015) 9:319–324
123
